Biotech Company News Biotechnology cancer Merck’s Keytruda wins U.S. FDA approval for bladder cancer drug By Staff Reports 2 weeks ago The U.S. Food and Drug Administration said on Wednesday it approved Merck & Co Inc’s
Biotech Company News Biotechnology cancer Cell Therapy Clinical Trials drug development Researchers Identify New Therapeutic Target for Colorectal Cancer By Staff Reports 3 weeks ago Researchers at the University of Toronto have identified a key protein that supports the growth
Biotech Company News Biotechnology Breast Cancer cancer Neurologic Drug Combined with Blood Pressure Medicine Reduces Breast Tumor Development in Mice By Staff Reports 3 weeks ago Adding a medication used to treat epilepsy, bipolar disorder and migraines to a blood pressure
Biotech Company News cancer Study finds less-aggressive chemotherapy after initial treatment for metastatic colorectal cancer to be more beneficial By Staff Reports 1 month ago A Mayo Clinic study involving 5,540 patients with metastatic colorectal cancer finds that maintenance chemotherapy after initial
Biotech Company News Biotechnology Diabetes Artificial pancreas system better controls blood glucose levels than current technology By Staff Reports 3 months ago A multicenter randomized clinical trial evaluating a new artificial pancreas system — which automatically monitors
age-related decline Alzheimers and Dementia Biotech Company News Biotechnology Bayer Selects Savonix Digital Cognitive Assessment Platform to Validate the Effects of Multivitamin Supplement Berocca in Malaysia By Staff Reports 4 months ago Savonix, a global leader in digital tests for cognitive health, and Bayer’s Consumer Health Division
Biotech Company News Biotechnology cancer Cell Therapy Heart Health Novel Therapeutic Shows Remarkable Efficacy in HepG2 Cell Lines By Staff Reports 5 months ago Q BioMed, Inc. and Chemveda Life Sciences announce the successful chemical synthesis of a unique
Biotech Company News Biotechnology genes Genetic Disorders Genomes genomic sequencing Mutation Discovery Leads to Precise Treatment for Child with Severe Lymphatic Disorder By Staff Reports 7 months ago Faced with a preteen boy in pain and struggling to breathe from a severe, deteriorating
Biotech Company News Biotechnology High Dose of Pfizer’s Xeljanz Raises Red Flag in a Post-Marketing Study By Staff Reports 11 months ago Pfizer‘s blockbuster rheumatoid arthritis drug Xeljanz, a JAK inhibitor, has been a strong performer for
Biotech Company News Merck to Acquire Immune Design By Staff Reports 11 months ago Merck and Immune Design announced that the companies have entered into a definitive agreement under
Biotech Company News Gilead misses key goal in NASH liver disease trial By Staff Reports 11 months ago CHICAGO (Reuters) – Gilead Sciences Inc said on Monday that a late-stage study of a
Biotech Company News Biotechnology Diabetes New Sensor to Monitor Blood Sugar Through a Breath By Staff Reports 12 months ago It’s a breath of fresh air for people with diabetics. A simple puff into a
Biotech Company News cancer Clinical Trials Eureka Therapeutics Announces Us FDA Clearance of IND Application for Phase 1/2 Trial of Et140202 Artemis T-Cell Therapy, For The Treatment of Liver Cancer By Staff Reports 12 months ago Eureka Therapeutics, Inc., a clinical stage biotechnology company developing antibody-TCR (AbTCR) T-cell therapies, announced that
Biotech Company News Q BioMed Seeks Multi-billion Dollar Opportunity with New Glaucoma Treatment Candidate By Staff Reports 12 months ago Shares of Q BioMed Inc.(OTCMKTS: QBIO) rose sharply on heavy volume after the company announced
Biotech Company News Bristol-Myers Squibb to Acquire Celgene By Staff Reports 1 year ago Bristol-Myers bulks up cancer portfolio with $74 billion Celgene deal (Reuters) – Bristol-Myers Squibb Co
Biotech Company News IntraBio Receives Niemann-Pick disease European Orphan Drug Designation for IB1000 Series By Staff Reports 1 year ago IntraBio Inc., a late-stage biopharmaceutical company developing novel therapies for rare “orphan” and common neurodegenerative